261 related articles for article (PubMed ID: 34479489)
21. Inhaled Marijuana and the Lungs.
Neff S; Drake MG; Slatore CG; Burnham E
Am J Respir Crit Care Med; 2021 Sep; 204(5):P9-P10. PubMed ID: 34499025
[No Abstract] [Full Text] [Related]
22. Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions.
Furrer D; Kröger E; Marcotte M; Jauvin N; Bélanger R; Ware M; Foldes-Busque G; Aubin M; Pluye P; Dionne CE
J Cannabis Res; 2021 Sep; 3(1):41. PubMed ID: 34481519
[TBL] [Abstract][Full Text] [Related]
23. The Effect of Cannabis-Based Medicine on Neuropathic Pain and Spasticity in Patients with Multiple Sclerosis and Spinal Cord Injury: Study Protocol of a National Multicenter Double-Blinded, Placebo-Controlled Trial.
Hansen JS; Hansen RM; Petersen T; Gustavsen S; Oturai AB; Sellebjerg F; Sædder EA; Kasch H; Rasmussen PV; Finnerup NB; Svendsen KB
Brain Sci; 2021 Sep; 11(9):. PubMed ID: 34573231
[TBL] [Abstract][Full Text] [Related]
24. Cannabidiol (CBD) and cognition in epilepsy.
Gaston TE; Martin RC; Szaflarski JP
Epilepsy Behav; 2021 Sep; 124():108316. PubMed ID: 34563808
[TBL] [Abstract][Full Text] [Related]
25. Refraining from use diminishes cannabis-associated epigenetic changes in human sperm.
Schrott R; Murphy SK; Modliszewski JL; King DE; Hill B; Itchon-Ramos N; Raburn D; Price T; Levin ED; Vandrey R; Corcoran DL; Kollins SH; Mitchell JT
Environ Epigenet; 2021; 7(1):dvab009. PubMed ID: 34557312
[TBL] [Abstract][Full Text] [Related]
26. Medical cannabis and cannabinoids for impaired sleep: a systematic review and meta-analysis of randomized clinical trials.
AminiLari M; Wang L; Neumark S; Adli T; Couban RJ; Giangregorio A; Carney CE; Busse JW
Sleep; 2022 Feb; 45(2):. PubMed ID: 34546363
[TBL] [Abstract][Full Text] [Related]
27. Cannabidiol enhances verbal episodic memory in healthy young participants: A randomized clinical trial.
Hotz J; Fehlmann B; Papassotiropoulos A; de Quervain DJ; Schicktanz NS
J Psychiatr Res; 2021 Nov; 143():327-333. PubMed ID: 34536664
[TBL] [Abstract][Full Text] [Related]
28. Clinical withdrawal symptom profile of synthetic cannabinoid receptor agonists and comparison of effects with high potency cannabis.
Craft S; Ferris JA; Barratt MJ; Maier LJ; Lynskey MT; Winstock AR; Freeman TP
Psychopharmacology (Berl); 2022 May; 239(5):1349-1357. PubMed ID: 34533608
[TBL] [Abstract][Full Text] [Related]
29. Cannabinoid receptor 1 expression is higher in muscle of old vs. young males, and increases upon resistance exercise in older adults.
Dalle S; Koppo K
Sci Rep; 2021 Sep; 11(1):18349. PubMed ID: 34526596
[TBL] [Abstract][Full Text] [Related]
30. Opioid and healthcare service use in medical cannabis patients with chronic pain: a prospective study.
Sznitman S; Mabouk C; Said Z; Vulfsons S
BMJ Support Palliat Care; 2023 Dec; 13(e2):e464-e468. PubMed ID: 34521640
[TBL] [Abstract][Full Text] [Related]
31. Generalized Anxiety Disorder 7-Item (GAD-7) Scores in Medically Authorized Cannabis Patients-Ontario and Alberta, Canada.
Lee C; Round JM; Hanlon JG; Hyshka E; Dyck JRB; Eurich DT
Can J Psychiatry; 2022 Jun; 67(6):470-480. PubMed ID: 34520280
[TBL] [Abstract][Full Text] [Related]
32. Cannabis and Athletic Performance.
Burr JF; Cheung CP; Kasper AM; Gillham SH; Close GL
Sports Med; 2021 Sep; 51(Suppl 1):75-87. PubMed ID: 34515970
[TBL] [Abstract][Full Text] [Related]
33. The Effectiveness of Cannabis and Cannabis Derivatives in Treating Lower Back Pain in the Aged Population: A Systematic Review.
Senderovich H; Wagman H; Zhang D; Vinoraj D; Waicus S
Gerontology; 2022; 68(6):612-624. PubMed ID: 34515130
[TBL] [Abstract][Full Text] [Related]
34. Cannabis use outcomes by past-month binge drinking status in the general United States population.
Vijapur SM; Levy NS; Martins SS
Drug Alcohol Depend; 2021 Nov; 228():108997. PubMed ID: 34508962
[TBL] [Abstract][Full Text] [Related]
35. Canada's cannabis legalization and drivers' traffic-injury presentations to emergency departments in Ontario and Alberta, 2015-2019.
Callaghan RC; Sanches M; Vander Heiden J; Asbridge M; Stockwell T; Macdonald S; Peterman BH; Kish SJ
Drug Alcohol Depend; 2021 Nov; 228():109008. PubMed ID: 34508959
[TBL] [Abstract][Full Text] [Related]
36. A standard THC unit for reporting of health research on cannabis and cannabinoids.
Freeman TP; Lorenzetti V
Lancet Psychiatry; 2021 Nov; 8(11):944-946. PubMed ID: 34506750
[No Abstract] [Full Text] [Related]
37. Cannabis use disorder among atrial fibrillation admissions, 2008-2018.
Chouairi F; Miller PE; Guha A; Clarke JR; Reinhardt SW; Ahmad T; Freeman JV; Desai NR; Friedman DJ
Pacing Clin Electrophysiol; 2021 Nov; 44(11):1934-1938. PubMed ID: 34506639
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic Drug-Drug Interactions among Antiepileptic Drugs, Including CBD, Drugs Used to Treat COVID-19 and Nutrients.
Karaźniewicz-Łada M; Główka AK; Mikulska AA; Główka FK
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502487
[TBL] [Abstract][Full Text] [Related]
39. Metabolic Consequences of Gestational Cannabinoid Exposure.
Lee K; Hardy DB
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502436
[TBL] [Abstract][Full Text] [Related]
40. The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases.
Lowe H; Toyang N; Steele B; Bryant J; Ngwa W
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
